#1
| |||
| |||
barc bleeding criteria |
#3
| |||
| |||
Re: barc bleeding criteria
No worries I will get the Special Report Standardized Bleeding Definitions for Cardiovascular Clinical Trials, so that it would be easy to check criteria. Here are some information The Bleeding complications have been associated with an increased risk of subsequent adverse outcomes, including MI, stroke, stent thrombosis, and death, in patients with ACS and in those undergoing percutaneous coronary intervention (PCI),5–10 as well as in the long-term antithrombotic setting The prevention of major bleeding may represent an important step in improving outcomes by balancing safety and efficacy in the contemporary treatment of ACS, Importance of Bleeding as an End Point Hemorrhagic complications occur with a frequency of 1% to 10% during treatment for ACS and after PCI. This wide variability in the measured incidence is due to several factors, including differences in patient characteristics, concomitant therapies, timing of event reporting, and definitions across data sets. For full information please check the file |
|